Phytocompounds and their molecular targets in immunomodulation: a review
Author:
Cherian Ayda1, Vadivel Velmurugan2, Thiruganasambandham Sundarrajan1, Madhavankutty Sreejith3
Affiliation:
1. Pharmaceutical Chemistry , SRM College of Pharmacy , Kattankulathur , Tamil Nadu , India 2. Pharmaceutical Chemistry , SRM College of Pharmacy, SRMIST , Kattankulathur , Chengalpattu District , Tamil Nadu , India 3. Pharmaceutical Chemistry , Nazareth College of Pharmacy , Thiruvalla , Kerala , India
Abstract
Abstract
Immune cells are important for the healthy function of every organ. The homeostasis of the immune system is selfregulated by T-cells, B-cells, and natural killer cells. The immunomodulation process of immune cells is part of the immunotherapy. According to therapeutic methods of immune responses are categorized as inducing (immunostimulant), amplification (immune booster), attenuation (immunomodulation), and prevention (immunosuppressive) actions. The prevalence of chronic immunological diseases like viral infections, allergies, and cancer is mainly due to the over-activation of the immune system. Further, immunomodulators are reported to manage the severity of chronic immunological disorders. Moreover, these immunomodulator-acting proteins are identified as potential molecular targets for the regulation of the immune system. Moreover, natural compound like phytocompounds are known to bind these targets and modulates the immune system. The specialized phytocompounds like curcumin, quercetin, stilbenes, flavonoids, and lignans are shown the immunomodulatory actions and ameliorate the immunological disorders. The present scenario of a COVID-19 pandemic situation has taught us the need to focus on strengthening the immune system and the development of the most promising immunotherapeutics. This review is focused on an overview of various phytocompounds and their molecular targets for the management of immunological disorders via immunosuppressants and immunostimulants actions.
Publisher
Walter de Gruyter GmbH
Subject
Drug Discovery,Pharmacology,General Medicine,Physiology
Reference141 articles.
1. Webb, NE, Bernshtein, B, Alter, G. Tissues: the unexplored Frontier of antibody mediated immunity. Curr Opin Virol 2021;47:52–67. https://doi.org/10.1016/j.coviro.2021.01.001. 2. Shanley, LC, Mahon, OR, Kelly, DJ, Dunne, A. Harnessing the innate and adaptive immune system for tissue repair and regeneration: considering more than macrophages. Acta Biomater 2021;133:208–21. https://doi.org/10.1016/j.actbio.2021.02.023. 3. Ge, Y, Wang, X, Guo, Y, Yan, J, Abuduwaili, A, Aximujiang, K, et al.. Gut microbiota influence tumor development and Alter interactions with the human immune system. J Exp Clin Cancer Res 2021;40:1–9. https://doi.org/10.1186/s13046-021-01845-6. 4. Chastin, SF, Abaraogu, U, Bourgois, JG, Dall, PM, Darnborough, J, Duncan, E, et al.. Effects of regular physical activity on the immune system, vaccination and risk of community-acquired infectious disease in the general population: systematic review and meta-analysis. Sports Med 2021;51:1673–88. https://doi.org/10.1007/s40279-021-01466-1. 5. Ali, M, Riad, M, Adhikari, P, Bhattarai, S, Gupta, A, Ali, E, et al.. Association between myasthenia gravis and systemic lupus erythematosus as a comorbid state. Cureus 2021;13:1–6. https://doi.org/10.7759/cureus.14719.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|